Journal
NATURE GENETICS
Volume 42, Issue 11, Pages 978-U98Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.687
Keywords
-
Categories
Funding
- National Cancer Institute, US National Institutes of Health [HHSN261200800001E]
- Cancer Research UK [10589, 12933] Funding Source: researchfish
- Medical Research Council [G0801056B] Funding Source: researchfish
- National Institute for Health Research [ACF-2006-02-005] Funding Source: researchfish
Ask authors/readers for more resources
We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which included 8,382 cases and 48,275 controls from 16 studies. In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 x 10(-12)) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 x 10(-11)) on 19q12 maps to CCNE1 and rs11892031 (P = 1 x 10(-7)) maps to the UGT1A cluster on 2q37.1. We confirmed four previously identified genome-wide associations on chromosomes 3q28, 4p16.3, 8q24.21 and 8q24.3, validated previous candidate associations for the GSTM1 deletion (P = 4 x 10(-11)) and a tag SNP for NAT2 acetylation status (P = 4 x 10(-11)), and found interactions with smoking in both regions. Our findings on common variants associated with bladder cancer risk should provide new insights into the mechanisms of carcinogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available